Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1970 Feb;46(532):94–96.

Anti-anginal drugs

Alberto Goldbarg, James Paxinos, Russell R Miller
PMCID: PMC2467008

Abstract

This review of studies on anti-anginal agents and their use in the anginal syndrome shows nitroglycerin to be unsurpassed in clinical effectiveness. It has a rapid onset of action. Its duration of action is relatively short but the need for a more prolonged effect has not been demonstrated. Most anginal attacks subside upon resting and the requirement for relief is immediate rather than prolonged. A long-acting anti-anginal agent would have some value if it could prevent precipitation of an anginal episode but there is no convincing evidence to indicate that these drugs have this capability. In general, clinical experience with long-acting nitrites is relatively unsatisfactory.

Full text

PDF
94

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BING R. J., BENNISH A., BLUEMCHEN G., COHEN A., GALLAGHER J. P., ZALESKI E. J. THE DETERMINATION OF CORONARY FLOW EQUIVALENT WITH COINCIDENCE COUNTING TECHNIC. Circulation. 1964 Jun;29:833–846. doi: 10.1161/01.cir.29.6.833. [DOI] [PubMed] [Google Scholar]
  2. Burke G. The treatment of angina pectoris. Geriatrics. 1967 May;22(5):168–174. [PubMed] [Google Scholar]
  3. COLE S. L., KAYE H., GRIFFITH G. C. Assay of anti-anginal agents. I. A curve analysis with multiple control periods. Circulation. 1957 Mar;15(3):405–413. doi: 10.1161/01.cir.15.3.405. [DOI] [PubMed] [Google Scholar]
  4. DEWAR H. A., HORLER A. R., NEWELL D. J. A clinical trial of penta-erythritol tetranitrate, a khellin derivative (recordil), and iproniazid in angina of effort. Br Heart J. 1959 Jul;21:315–322. doi: 10.1136/hrt.21.3.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Epstein S. E., Braunwald E. Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med. 1966 Nov 17;275(20):1106–contd. doi: 10.1056/NEJM196611172752006. [DOI] [PubMed] [Google Scholar]
  6. Friedberg C. K. Angina pectoris. Geriatrics. 1967 Jun;22(6):144–155. [PubMed] [Google Scholar]
  7. KALMANSON F. M., DRENICK E. J., BINDER M. J., ROSOVE L. Pentaerythritol tetranitrate in the treatment of angina pectoris; clinical evaluation. AMA Arch Intern Med. 1955 Jun;95(6):819–822. doi: 10.1001/archinte.1955.00250120055006. [DOI] [PubMed] [Google Scholar]
  8. ORAM S., SOWTON E. Failure of propatylnitrate and pentaerythritol tetranitrate to prevent attacks of angina pectoris. Br Med J. 1961 Dec 30;2(5269):1745–1746. doi: 10.1136/bmj.2.5269.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. RISEMAN J. E., ALTMAN G. E., KORETSKY S. Nitroglycerin and other nitrites in the treatment of angina pectoris; comparison of six preparations and four routes of administration. Circulation. 1958 Jan;17(1):22–39. doi: 10.1161/01.cir.17.1.22. [DOI] [PubMed] [Google Scholar]
  10. Rabkin R., Stables D. P., Levin N. W., Suzman M. M. The prophylactic value of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):370–383. doi: 10.1016/0002-9149(66)90056-7. [DOI] [PubMed] [Google Scholar]
  11. Russek H. I. The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and pentaerythritol tetranitrate. Am J Med Sci. 1966 Jul;252(1):9–20. doi: 10.1097/00000441-196607000-00002. [DOI] [PubMed] [Google Scholar]
  12. SANDLER G. Clinical evaluation of propatylnitrate in angina pectoris. Br Med J. 1961 Dec 30;2(5269):1741–1744. doi: 10.1136/bmj.2.5269.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES